- Notice
The Association of Hyperdifferent Fields Tokyo 2026] Keynote Speech by Eiichiro Mori, Associate Professor, Nara Medical University "I want to see the movement of molecules! /March 7, 2026 13:00-13:20
2025.11.18
Riverness will sponsor the event.Hyper Interdisciplinary Conference Tokyo 2026Dr. Eiichiro Mori, Associate Professor of Basic Medicine for the Future, Faculty of Medicine, Nara Medical University, will deliver the keynote lecture at the "Molecular Science" conference. He will speak on the topic of "I want to see the movement of molecules! He will be speaking on the topic of "Molecules in Motion!
I want to see how molecules move!
In the 2000s, the human genome analysis revealed information about the genes in the human genome, and in the 2010s, the shape of the proteins that result from the translation of genes was revealed in considerable detail by techniques such as X-ray crystallography and cryo-EM. and cryo-electron microscopy. Still, not all proteins are visible. Many human proteins have parts that do not have a definite shape, and these parts are not easy to see because they involve movement. Molecules that can be crystallized or frozen and observed can be seen, but molecules in motion are difficult to see. We cannot see them, but they are difficult to see! I want to see!" In the 2020s, my desire to "see molecules in motion! I would like to introduce my research on the movement of molecules. I would like to introduce my efforts to see the movement of molecules.
In the program of the Association of Hyperdifferent Fields Tokyo 2026
Date: Saturday, March 7, 2026, 13:00-13:20
Place: Bellesalle Shinjuku Grand Conference Center
(Sumitomo Fudosan Shinjuku Grand Tower 5F, 8-17-1 Nishi-Shinjuku, Shinjuku-ku, Tokyo)
speaker
Mr. Eiichiro Mori
Associate Professor, Nara Medical University School of Medicine
Representative Director, MOLMIL Corporation
Spent his childhood in Chicago, Illinois, U.S.A. with co-founder Masataka Yamamoto (Director and COO). While a student at Nara Medical University, he engaged in basic research in cell biology. After completing a clinical internship at Nara Medical University Hospital, he went to the University of Texas, U.S.A., for further study. Through research into the pathophysiology of amyotrophic lateral sclerosis (ALS), a neurological intractable disease, he established MORMIL in June 2022 with scientific advisors Shunsuke Tomita (AIST) and Tomohide Saio (University of Tokushima), and Masataka Yamamoto and Kota Togami (CFO). The company received the KRP Award at HVC KYOTO 2023, the Grand Prize at Biotech Grand Prix 2023, and the Metagen Award, among others.
Registration for auditing and participation is now open.
We look forward to welcoming many people from academia, venture companies, large corporations, local medium-sized and small companies, local factories, producers, local governments, junior high and high school students, and technical college students to the Hyperdifferent Field Conference.
Contact Us
For inquiries regarding this matter, please contact
Liverness Corporation (Nakajima, Seno)
TEL: 03-5227-4198
e-mail : [email protected]